Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.

PloS one - 1 Jan 2014

Opstad Trine B, Arnesen Harald, Pettersen Alf Å, Seljeflot Ingebjørg

Abstract excerpt

BACKGROUND AND OBJECTIVES: Elevated levels of matrix metalloproteinase (MMP)-9 have been associated with the metabolic syndrome (MetS) and cardiovascular events. The MMP-9 -1562 C/T polymorphism has furthermore been shown as a risk factor for coronary artery disease (CAD). The non-favourable cardiometabolic state in MetS may increase the risk. We aimed to investigate the influence of MMP-9 -1562 C/T polymorphism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytosine

Share to Genetic Association Studies

Share to Matrix Metalloproteinase 9

Share to Metabolic Syndrome

Share to Thymine

Share to Tissue Inhibitor of Metalloproteinase-1

Source

Open in PubMed Open full text

Identifiers

PMID: 25191702
DOI: 10.1371/journal.pone.0106816
PMCID: PMC4156385

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.PMID 25191702Read ↗

High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome.Semantic proximity Read ↗

Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease.Semantic proximity Read ↗

MMP9 Gene Polymorphism (rs3918242) Increases the Risk of Cardiovascular Disease in Type 2 Diabetes PatientsSemantic proximity Read ↗

Genetic variants of matrix metalloproteinase (MMP2) gene influence metabolic syndrome susceptibility.Semantic proximity Read ↗

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.Semantic proximity Read ↗

Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.Semantic proximity Read ↗

The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.Semantic proximity Read ↗

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.Semantic proximity Read ↗

Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.Semantic proximity Read ↗

Meta-analysis of MMP9-562C/T and the risk of coronary heart disease.Semantic proximity Read ↗

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients.Semantic proximity Read ↗

Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.